These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69. Paradoxical behaviour of antithrombin III during hemodialysis and its prevention with prostacyclin. Turney JH; Fewell M; Williams LC; Dodd N; Weston MJ Clin Nephrol; 1982 Jan; 17(1):31-5. PubMed ID: 7035043 [No Abstract] [Full Text] [Related]
73. Prostacyclin as the sole antithrombotic agent for acute renal failure hemodialysis. Hory B; Saint-Hillier Y; Perol JC Nephron; 1983; 33(1):71. PubMed ID: 6339968 [No Abstract] [Full Text] [Related]
74. Rationale and proposal for use of prostacyclin in thrombotic thrombocytopenic purpura therapy. Cocchetto DM; Cook L; Cato AE; Niedel JE Semin Thromb Hemost; 1981; 7(1):43-51. PubMed ID: 7015516 [No Abstract] [Full Text] [Related]
75. Some remarks on the complex behaviour of platelet function during and after prostacyclin treatment. Sinzinger H; Silberbauer K; Leithner C; Schwarz M Vasa; 1981; 10(4):348-9. PubMed ID: 7032112 [No Abstract] [Full Text] [Related]
76. [PGI2 therapy in congestive heart failure and its effects on the sympathetic nervous activity]. Yui Y; Nakajima H; Wakabayashi A; Kawai C Kokyu To Junkan; 1983 Jan; 31(1):59-61. PubMed ID: 6344169 [No Abstract] [Full Text] [Related]
77. Use of prostacyclin in persistent fetal circulation. Lock JE; Olley PM; Coceani F; Swyer PR; Rowe RD Lancet; 1979 Jun; 1(8130):1343. PubMed ID: 87797 [No Abstract] [Full Text] [Related]
78. Epoprostenol and severe arterial disease. Olsson AG Lancet; 1983 Mar; 1(8326 Pt 1):711-2. PubMed ID: 6132070 [No Abstract] [Full Text] [Related]
79. Reversal of oleic acid-induced respiratory distress by prostacyclin (PGI2). Miyazawa T; Hiramoto M; Hiramoto T; Nishida O Respir Physiol; 1982 Mar; 47(3):351-64. PubMed ID: 6808627 [TBL] [Abstract][Full Text] [Related]